ArticleAmerican journal of cancer research2024
Human bone marrow mesenchymal stem cell-driven LncRNA PTCSC3 upregulation within lung adenocarcinoma cells reduces erlotinib resistance by mitigating Wnt/β-Catenin pathway.
Bohang Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.